Table 2

Clinical characteristics of the six patients who received full ophthalmic assessment

Case noAgeVisual acuityColour visionOnsetOptic disc appearanceRNFL (μm) ODRNFL (μm) OSMacular thickness (μm) ODMacular thickness (μm) OSMacular volume (μm) ODMacular volume (μm) OSTreatmentSmoker?
VI-201220/25 OU1/8 OU3 months subacutePallor8986250.2245.47.076.94Coeq10
600 mg
VI-191420/400 OU1/8 OUAcuteDisc oedema10996242235.66.846.66Coeq10
600 mg
VI-1722CF OU0/8Acute (5 years ago)Pallor5649217.8221.86.166.27Coeq10
600 mg
1 pack/day
VI-101820/40 OD
20/25 OS
1/8 OUAcute (4 years ago)Pallor7273229.2230.76.486.52None
V-12420/40 OU1/8 OUAcute (4 years ago)Disc oedema then pallor5659233.2229.56.596.49None
VI-91520/400 OD
20/30 OS
1/8 OD
8/8 OS
Acute (2 weeks)Disc oedema OD >OS126130253.52677.177.55Coeq10
600 mg
  • Coeq10, coenzyme q10; OD, right eye; OS, left eye; OU, both eyes; RNFL, retinal nerve layer thickness.